244 related articles for article (PubMed ID: 29192323)
21. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
[TBL] [Abstract][Full Text] [Related]
22. Effects of propranolol on glucose metabolism in hemangioma-derived endothelial cells.
Yang K; Li X; Qiu T; Zhou J; Gong X; Lan Y; Ji Y
Biochem Pharmacol; 2023 Dec; 218():115922. PubMed ID: 37956892
[TBL] [Abstract][Full Text] [Related]
23. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
J Cutan Med Surg; 2012; 16(5):317-23. PubMed ID: 22971306
[TBL] [Abstract][Full Text] [Related]
24. The ester derivatives obtained by C-ring modification of podophyllotoxin-induced apoptosis and inhibited proliferation in Hemangioma Endothelial Cells via downregulation of PI3K/Akt signaling pathway.
Zhao Y; Li D; Han Y; Wang H; Du R; Yan Z
Chem Biol Drug Des; 2022 Jun; 99(6):828-838. PubMed ID: 35184389
[TBL] [Abstract][Full Text] [Related]
25. Serum concentrations of VEGF and bFGF in the course of propranolol therapy of infantile hemangioma in children: Are we closer to understand the mechanism of action of propranolol on hemangiomas?
Babiak-Choroszczak L; Giżewska-Kacprzak K; Gawrych E; Fischer K; Walecka A; Puchalska-Niedbał L; Rajewska-Majchrzak J; Bagłaj M
Adv Clin Exp Med; 2018 May; 27(5):703-710. PubMed ID: 29790692
[TBL] [Abstract][Full Text] [Related]
26. Propranolol-Loaded Mesoporous Silica Nanoparticles for Treatment of Infantile Hemangiomas.
Wu H; Wang X; Zheng J; Zhang L; Li X; Yuan WE; Liu X
Adv Healthc Mater; 2019 May; 8(9):e1801261. PubMed ID: 30838782
[TBL] [Abstract][Full Text] [Related]
27. [Effects of oral propranolol on urine bFGF, MMP-2, MMP-9 expression in children with proliferative infantile hemangioma].
Yuan WL; Wang XK
Shanghai Kou Qiang Yi Xue; 2022 Aug; 31(4):400-405. PubMed ID: 36710554
[TBL] [Abstract][Full Text] [Related]
28. Propranolol versus captopril in the treatment of infantile hemangioma (IH): A randomized controlled trial.
Zaher H; Rasheed H; El-Komy MM; Hegazy RA; Gawdat HI; Abdel Halim DM; Abdel Hay RM; Hegazy RA; Mohy AM
J Am Acad Dermatol; 2016 Mar; 74(3):499-505. PubMed ID: 26685718
[TBL] [Abstract][Full Text] [Related]
29. Kinetic and Angiogenic Activity of Circulating Endothelial Colony Forming Cells in Patients with Infantile Haemangioma Receiving Propranolol.
Campanelli R; Codazzi AC; Poletto V; Abbà C; Catarsi P; Fois G; Avanzini MA; Brazzelli V; Tzialla C; De Silvestri A; Tinelli C; Licari A; Berra-Romani R; Zuccolo E; Moccia F; Mannarino S; Rosti V; Massa M
Thromb Haemost; 2019 Feb; 119(2):274-284. PubMed ID: 30609443
[TBL] [Abstract][Full Text] [Related]
30. Infantile hemangioma: pathogenesis and mechanisms of action of propranolol.
Rotter A; de Oliveira ZNP
J Dtsch Dermatol Ges; 2017 Dec; 15(12):1185-1190. PubMed ID: 29193649
[TBL] [Abstract][Full Text] [Related]
31. E-selectin mediates stem cell adhesion and formation of blood vessels in a murine model of infantile hemangioma.
Smadja DM; Mulliken JB; Bischoff J
Am J Pathol; 2012 Dec; 181(6):2239-47. PubMed ID: 23041613
[TBL] [Abstract][Full Text] [Related]
32. Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation.
Munabi NC; England RW; Edwards AK; Kitajewski AA; Tan QK; Weinstein A; Kung JE; Wilcox M; Kitajewski JK; Shawber CJ; Wu JK
Stem Cells Transl Med; 2016 Jan; 5(1):45-55. PubMed ID: 26574555
[TBL] [Abstract][Full Text] [Related]
33. Enhanced rapamycin delivery to hemangiomas by lipid polymer nanoparticles coupled with anti-VEGFR antibody.
Li H; Teng Y; Xu X; Liu J
Int J Mol Med; 2018 Jun; 41(6):3586-3596. PubMed ID: 29512710
[TBL] [Abstract][Full Text] [Related]
34. Urea immunoliposome inhibits human vascular endothelial cell proliferation for hemangioma treatment.
Wang Z; Li J; Xu X; Duan X; Cao G
World J Surg Oncol; 2013 Nov; 11():300. PubMed ID: 24266957
[TBL] [Abstract][Full Text] [Related]
35. Propranolol therapy for infantile hemangioma: our experience.
Zhang L; Wu HW; Yuan W; Zheng JW
Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428
[TBL] [Abstract][Full Text] [Related]
36. Expression of TGFBI in infantile hemangioma tissues and its effect on the biological characteristics of hemangioma endothelial cells.
Li M; Yang E; Li Y; Geng Y; Wu H; Zhang D
Hua Xi Kou Qiang Yi Xue Za Zhi; 2023 Feb; 41(1):29-36. PubMed ID: 38596938
[TBL] [Abstract][Full Text] [Related]
37. Propranolol inhibits the angiogenic capacity of hemangioma endothelia via blocking β-adrenoceptor in mast cell.
Ye Y; Zhong H; Dou L; Song W; Dong C; Lu W; Dong K; Li K; Li J; He L; Gao W; Xia C; Wang L
Pediatr Res; 2022 Aug; 92(2):424-429. PubMed ID: 34650198
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of Propranolol Between 6 and 12 Months of Age in High-Risk Infantile Hemangioma.
Baselga E; Dembowska-Baginska B; Przewratil P; González-Enseñat MA; Wyrzykowski D; Torrelo A; López Gutiérrez JC; Rychłowska-Pruszyńska M; de Lucas-Laguna R; Esteve-Martinez A; Roé E; Zaim M; Menon Y; Gautier S; Lebbé G; Bouroubi A; Delarue A; Voisard JJ
Pediatrics; 2018 Sep; 142(3):. PubMed ID: 30082451
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial.
Kim KH; Choi TH; Choi Y; Park YW; Hong KY; Kim DY; Choe YS; Lee H; Cheon JE; Park JB; Park KD; Kang HJ; Shin HY; Jeong JH
JAMA Dermatol; 2017 Jun; 153(6):529-536. PubMed ID: 28423174
[TBL] [Abstract][Full Text] [Related]
40. Development of rapamycin-encapsulated exosome-mimetic nanoparticles-in-PLGA microspheres for treatment of hemangiomas.
Li H; Wang X; Guo X; Wan Q; Teng Y; Liu J
Biomed Pharmacother; 2022 Apr; 148():112737. PubMed ID: 35276517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
